160 related articles for article (PubMed ID: 1381268)
1. Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
Giardina MG; Matarazzo M; Varriale A; Morante R; Napoli A; Martino R
Cancer; 1992 Sep; 70(5):1044-8. PubMed ID: 1381268
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
4. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
[TBL] [Abstract][Full Text] [Related]
5. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
Shen W; Shen DM
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
7. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Bukofzer S; Stass PM; Kew MC; de Beer M; Groeneveld HT
Br J Cancer; 1989 Mar; 59(3):417-20. PubMed ID: 2467686
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
[TBL] [Abstract][Full Text] [Related]
9. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
[TBL] [Abstract][Full Text] [Related]
10. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Gan Y; Liang Q; Song X
Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
Yu ZW; Duan FL; Yang XW
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
[TBL] [Abstract][Full Text] [Related]
13. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
[TBL] [Abstract][Full Text] [Related]
14. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
Hutchinson WL; Johnson PJ; Du MQ; Williams R
Clin Sci (Lond); 1991 Aug; 81(2):177-82. PubMed ID: 1716188
[TBL] [Abstract][Full Text] [Related]
15. Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Marotta F; Chui DH; Safran P; Zhang SC
Dig Dis Sci; 1991 Jul; 36(7):993-7. PubMed ID: 1712699
[TBL] [Abstract][Full Text] [Related]
16. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
17. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
18. Enhanced detection of hepatocellular carcinoma.
el-Houseini ME; Mohammed MS; Elshemey WM; Hussein TD; Desouky OS; Elsayed AA
Cancer Control; 2005 Oct; 12(4):248-53. PubMed ID: 16258497
[TBL] [Abstract][Full Text] [Related]
19. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
[TBL] [Abstract][Full Text] [Related]
20. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
